Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas P Restifo

Showing results (221-230 of 260) with videos related to

Pageof 26
Sort By:
The Journal of Clinical Investigation|January 6, 2016
The transcription factor BACH2 promotes tumor immunosuppressionRahul Roychoudhuri, Robert L Eil, David Clever, et al.
Molecular Cell|February 5, 2019
Ribosomal Proteins Regulate MHC Class I Peptide Generation for ImmunosurveillanceJiajie Wei, Rigel J Kishton, Matthew Angel, et al.
Immunity|December 3, 2020
Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human LymphomasDevin Dersh, James D Phelan, Megan E Gumina, et al.
Nature Immunology|February 20, 2019
The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunitySanjivan Gautam, Jessica Fioravanti, Wei Zhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvantWillem W Overwijk, Karin E de Visser, Felicia H Tirion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
Antigen Experienced T Cells from Peripheral Blood Recognize p53 NeoantigensParisa Malekzadeh, Rami Yossef, Gal Cafri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2016
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen SettingClare Y Slaney, Bianca von Scheidt, Alexander J Davenport, et al.
The Journal of Experimental Medicine|August 20, 2003
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cellsWillem W Overwijk, Marc R Theoret, Steven E Finkelstein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2015
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic MelanomaJoal D Beane, Gary Lee, Zhili Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with responsePaul F Robbins, Sadik H Kassim, Thai L N Tran, et al.
Pageof 26

Showing results (221-230 of 260) with videos related to

Sort By:
Pageof 26
The Journal of Clinical Investigation|January 6, 2016
The transcription factor BACH2 promotes tumor immunosuppressionRahul Roychoudhuri, Robert L Eil, David Clever, et al.
Molecular Cell|February 5, 2019
Ribosomal Proteins Regulate MHC Class I Peptide Generation for ImmunosurveillanceJiajie Wei, Rigel J Kishton, Matthew Angel, et al.
Immunity|December 3, 2020
Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human LymphomasDevin Dersh, James D Phelan, Megan E Gumina, et al.
Nature Immunology|February 20, 2019
The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunitySanjivan Gautam, Jessica Fioravanti, Wei Zhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvantWillem W Overwijk, Karin E de Visser, Felicia H Tirion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
Antigen Experienced T Cells from Peripheral Blood Recognize p53 NeoantigensParisa Malekzadeh, Rami Yossef, Gal Cafri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2016
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen SettingClare Y Slaney, Bianca von Scheidt, Alexander J Davenport, et al.
The Journal of Experimental Medicine|August 20, 2003
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cellsWillem W Overwijk, Marc R Theoret, Steven E Finkelstein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2015
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic MelanomaJoal D Beane, Gary Lee, Zhili Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with responsePaul F Robbins, Sadik H Kassim, Thai L N Tran, et al.
Pageof 26